Past-Year Lysergic Acid Diethylamide Use in United States Sexual Minorities from 2015 to 2019
Psychedelic Medicine · 01.12.2026 · 4 (4) · 281-290
DOI: 10.1177/28314425251410086 ↗Kurz gefasst
Fachartikel in der Zeitschrift Psychedelic Medicine, online erschienen am 26.12.2025. Verfasst von Brian S Barnett und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Psychiatry and Psychology, Center for Behavioral Health, Neurological Institute, Cleveland Clinic, Cleveland, Ohio, USA. Die Arbeit nennt 68 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Objective
This study aimed to characterize changes in estimated past-year lysergic acid diethylamide (LSD) use among sexual minorities in the United States using nationally representative data and to compare correlates of LSD use between lesbian, gay, and bisexual individuals (LGB) and heterosexual individuals.
Method
Using National Survey on Drug Use and Health data on adults from 2015 to 2019, we investigated correlates of past-year LSD use among LGB individuals compared with heterosexual individuals and changes in the prevalence of past-year LSD use during that period. Correlates were identified with weighted logistic regression.
Results
LGB individuals constituted approximately 5% of the sample. From 2015 to 2019 estimated prevalence of past-year LSD use rose 43% in heterosexual individuals, 58% in bisexual individuals, and 106% in lesbian/gay individuals. The relative risk for LSD use ranged from 3.3 to 4.4 times higher for LGB individuals compared with heterosexual individuals during the study period, depending on the year. Interaction analysis found that living in poverty, being divorced versus married, living in a small metropolitan area versus a non-metropolitan area, and past-year suicide attempt were unique correlates of past-year LSD use for heterosexual individuals compared with LGB individuals.
Conclusions
Sexual minorities are at increased risk of past-year LSD use compared with heterosexual individuals. There were notable increases in past-year LSD use from 2015 to 2019 among heterosexual, bisexual, and lesbian/gay individuals, with a marked increase in the latter group. These findings highlight the possible need for targeted LSD harm reduction strategies based on sexual identity and more inclusive research on psychedelic use.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Psychiatry and Psychology, Center for Behavioral Health, Neurological Institute, Cleveland Clinic, Cleveland, Ohio, USA.
- Cleveland Clinic Lerner College of Medicine at Case Western Reserve University, Cleveland, Ohio, USA.
- Department of Behavioral Health and Neurological Sciences, Children's Institute, Cleveland Clinic, Cleveland, Ohio, USA.
- Department of Quantitative Health Sciences, Cleveland Clinic, Cleveland, Ohio, USA.
- Center for Populations Health Research, Cleveland Clinic, Cleveland, Ohio, USA.
- Department of Psychiatry, Faculty of Medicine & Dentistry, University of Alberta, Edmonton, Canada.
ORCID-Profile: Brian S Barnett
Zitieren
APA
Barnett, B. S., Anand, A., Falcone, T., Altinay, M., Dewey, E. N., & Weleff, J. (2026). Past-Year Lysergic Acid Diethylamide Use in United States Sexual Minorities from 2015 to 2019. Psychedelic Medicine, 4(4), 281-290. https://doi.org/10.1177/28314425251410086
Vancouver
Barnett BS, Anand A, Falcone T, Altinay M, Dewey EN, Weleff J. Past-Year Lysergic Acid Diethylamide Use in United States Sexual Minorities from 2015 to 2019. Psychedelic Medicine. 2026;4(4):281-290. doi:10.1177/28314425251410086
BibTeX
@article{Barnett2026,
author = {Barnett, Brian S and Anand, Akhil and Falcone, Tatiana and Altinay, Murat and Dewey, Elizabeth N and Weleff, Jeremy},
title = {Past-Year Lysergic Acid Diethylamide Use in United States Sexual Minorities from 2015 to 2019},
journal = {Psychedelic Medicine},
year = {2026},
volume = {4},
number = {4},
pages = {281--290},
doi = {10.1177/28314425251410086}
}
EUVIMED